Financial Ratios

ADS DIAGNOSTIC LTD.

NSE : NABSE : 523031ISIN CODE : Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 11.3411.34
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.852.001.532.153.87
   CEPS(Rs)2.723.272.853.384.60
   DPS(Rs)0.900.800.000.000.90
   Book NAV/Share(Rs)19.6918.4616.4414.8613.51
   Tax Rate(%)16.5422.1423.8023.9623.33
Margin Ratios
   Core EBITDA Margin(%)11.239.781.324.2017.19
   EBIT Margin(%)6.9610.6310.838.1717.38
   Pre Tax Margin(%)3.665.594.684.5812.37
   PAT Margin (%)3.054.353.573.489.49
   Cash Profit Margin (%)4.497.106.635.4811.27
Performance Ratios
   ROA(%)3.383.312.112.776.35
   ROE(%)9.7111.499.8115.1533.62
   ROCE(%)12.3412.5911.5016.2028.96
   Asset Turnover(x)1.110.760.590.790.67
   Sales/Fixed Asset(x)6.303.442.844.093.28
   Working Capital/Sales(x)4.653.623.428.248.87
Efficiency Ratios
   Fixed Capital/Sales(x)0.160.290.350.240.31
   Receivable days84.71143.48185.89104.0598.51
   Inventory Days145.32209.29273.27231.17272.13
   Payable days144.06247.43360.70311.67592.80
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.350.490.660.520.25
   EV/Core EBITDA(x)2.293.694.775.091.30
   EV/EBIT(x)4.964.646.126.341.43
   EV/CE(x)0.380.420.430.400.13
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)31.707.02-30.2551.0940.22
   Core EBITDA Growth(%)48.653.01-4.68-19.8768.04
   EBIT Growth(%)-13.755.02-7.50-29.0278.17
   PAT Growth(%)-7.6430.62-28.59-44.51301.02
   EPS Growth(%)-7.6430.62-28.59-44.51301.03
Financial Stability Ratios
   Total Debt/Equity(x)0.580.971.451.660.60
   Current Ratio(x)1.371.371.281.131.08
   Quick Ratio(x)0.700.660.650.500.38
   Interest Cover(x)2.112.111.762.283.47
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.